Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Cash from Investing Activities data on file, last reported at -$61173.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 95.02% year-over-year to -$61173.0; the trailing twelve-month figure through Mar 2026 stood at -$3.5 million (down 218.25% YoY), and the FY2025 full-year result was -$4.7 million, down 8236.82% from the prior year.
• Cash from Investing Activities climbed to -$61173.0 in Q1 2026, from -$3.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $680805.0 in Q3 2022 to a low of -$13.5 million in Q1 2022.
• A 5-year average of -$1.1 million and a median of -$95073.0 in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities jumped 728.95% in 2022 and plunged 11363.83% in 2025, its largest moves.
• Tracing CPIX's Cash from Investing Activities over 5 years: stood at -$640772.0 in 2022, then jumped by 140.68% to $260639.0 in 2023, then plunged by 110.29% to -$26809.0 in 2024, then sank by 11363.83% to -$3.1 million in 2025, then jumped by 98.01% to -$61173.0 in 2026.
• Business Quant data shows CPIX's Cash from Investing Activities at -$61173.0 in Q1 2026, -$3.1 million in Q4 2025, and -$690837.0 in Q3 2025.